Rapidly progressive cerebellar ataxia in West Wales

Khalid Ali1, Reem Amin, Kathir G Yoganathan

  • 1Neurology Department, Morriston Hospital, Swansea, UK.

BMJ Case Reports
|November 23, 2013
PubMed

Insights

Progressive multifocal leukoencephalopathy (PML), a severe brain disease caused by JC virus, affects immunocompromised individuals. Treatment focuses on immune reconstitution, as demonstrated in an HIV-positive patient with cerebellar ataxia.

Area of Science:

  • Neuroscience
  • Infectious Diseases

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a severe demyelinating central nervous system disease caused by JC virus infection, often leading to fatal or disabling outcomes.
  • PML occurs in patients with cell-mediated immunosuppression, historically linked to hematological malignancies and rheumatological diseases, with a significant increase in incidence due to the HIV epidemic.
  • The advent of monoclonal antibody therapies, such as natalizumab for multiple sclerosis, has also been associated with PML development.

Observation:

  • Clinical presentation includes cognitive decline, visual disturbances, and hemiparesis.
  • Diagnosis is typically established through clinicoradiological findings and detection of JC virus DNA in cerebrospinal fluid (CSF) via PCR, with brain biopsy rarely required.

Findings:

  • The case study details a 47-year-old male presenting with progressive cerebellar ataxia, confirmed as PML.
  • Investigations revealed the patient was HIV positive, highlighting a common risk factor for PML.
  • Literature review on PML management and presentation is included.

Implications:

  • Immune reconstitution is the primary therapeutic strategy for managing PML.
  • Understanding the diverse etiologies and clinical presentations of PML is crucial for timely diagnosis and management.
  • The association of PML with both viral infections and iatrogenic immunosuppression underscores the importance of monitoring immune status in at-risk populations.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
31
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
166
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
29
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35